Daljeet Kohli advises caution on banks near-term due to asset quality and NIM pressures, suggesting a re-look after consolidation. He remains positive on NBFCs and power financers for structural growth. Kohli also maintains a bullish outlook on pharma, expecting limited impact from US tariffs and a rebound in domestic demand post-calamities.